The potential inhibitory impact of curcumin, epigallocatechin gallate and their combinations on infectious bronchitis virus in vivo
- Author:
Fadwa Amin
1
;
Sabry Tamam
2
;
Abdou Allayeh
3
;
Mai Raslan
1
Author Information
- Publication Type:Journal Article
- Keywords: Infectious bronchitis virus; Curcumin; EGCG; Coronvirus; Real time PCR
- MeSH: Infectious bronchitis virus--physiology; Curcumin; Catechin
- From:Malaysian Journal of Microbiology 2022;18(1):47-57
- CountryMalaysia
- Language:English
-
Abstract:
Aims:Infectious bronchitis virus (IBV) is a highly contagious, acute viral respiratory disease that mostly affects chickens. The poultry sector has suffered enormous losses as a result of IBV. Currently, live attenuated vaccines are routinely used to prevent and control IBV. However, due to the enormous genetic variety, vaccinations are becoming ineffective, with low cross-protection effects among vaccine serotypes. The present study aimed at investigating the possible antiviral effects of curcumin, epigallocatechin gallate (EGCG) and their mixtures against IBV in vivo.
Methodology and results:Curcumin, EGCG and their combinations were administered to infected and uninfected chicken groups and viral load titers were determined by real-time PCR. The clinical symptoms of both the negative and positive control groups were also compared. Finally, the trachea tissues of each group were examined histopathologically. According to our findings, the viral titer and the clinical signs dropped significantly during the pretreatment infection procedure. Curcumin, EGCG and their combinations also show significant antiviral activities.
Conclusion, significance and impact of study:This study clearly shown that natural compounds and their combinations, such as curcumin or/and ECGC can reduce viral pathogenicity in vivo, suggesting that they might have therapeutic implications in the poultry sector. - Full text:20.2022my0005.pdf
